0

[Antigenicity of Hepatitis C Virus F Protein and Serum Prevalence of anti-F in HCV-infected Patients]

Sheng-Wen Shao, Wen-Bin Wu, Jian-Guo Yu, Ping Zhao, Zhong-Tian Qi

Zhonghua Gan Zang Bing Za Zhi. 2006 Dec;14(12):890-3.

PMID: 17196130

Abstract:

Objective:
To examine the antigenicity of hepatitis C virus (HCV) F protein and investigate serum prevalence of anti-F in HCV-infected patients.
Methods:
Eleven pairs of overlapping primers were used to synthesize the full-length HCV f gene, from which the truncated HCV f65 gene fragment was amplified by PCR. HCV f65 gene was then cloned into pET32a(+), and transformed into E. coli strain Plyss (DE3). This recombinant E.coli was induced by IPTG for the production of HCV F65 protein. The expressed HCV F65 protein, purified by Ni-NTA agarose, was further used in ELISA to detect serum anti-F, and to immunize rabbits for making polyclonal anti-F. The rabbit polyclonal anti-F was purified by Staphylococcus aureus protein A agarose.
Results:
After recombinant pET32a(+)-f65 was constructed successfully, HCV F65 protein was expressed and purified. The purified HCV F65 protein was used as a capture antigen in ELISA to detect serum anti-F in HCV infected patients (n = 30). The result showed that the mean A450 value and the positive rate of serum anti-F were 0.125+/-0.061 and 63.3%, respectively. The rabbit-derived polyclonal anti-F reacted specifically with HCV F65 protein, of which the titer was 1:30,000.
Conclusion:
Our expressed HCV F65 protein is of antigenicity, and can be used to determine serum anti-F. Anti-F IgG does exist in the sera of the HCV-infected patients. Moreover, the rabbit-derived polyclonal anti-F can be used to detect HCV F protein.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
IAR42411030 Protein A-Agarose from Staphylococcus aureus Protein A-Agarose from Staphylococcus aureus Price
qrcode